AI assistant
Sending…
Sana Biotechnology, Inc. — Director's Dealing 2021
Feb 5, 2021
32303_dirs_2021-02-05_0954c5e0-ecab-40cd-b04d-352315064d9f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sana Biotechnology, Inc. (SANA)
CIK: 0001770121
Period of Report: 2021-02-03
Reporting Person: Bishop Hans Edgar (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-03 | Stock Option (Right to Buy) | $25.00 | A | 14000 | Acquired | 2031-02-02 | Common Stock (14000) | Direct |
Footnotes
F1: The stock option shall vest and become exercisable in full on February 3, 2022.
More from Sana Biotechnology, Inc.
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
May 15
Share Issue/Capital Change
2026
May 11
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Board/Management Information
2026
Apr 24
Capital/Financing Update
2026
Apr 13
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Mar 4
Capital/Financing Update
2026
Mar 3